The rhamnolipids market size is expected to see strong growth in the next few years. It will grow to $4.37 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to stricter environmental regulations, expansion of sustainable agriculture, growth of green cosmetics, advances in fermentation technology, rising demand for biodegradable ingredients. Major trends in the forecast period include rising adoption of biosurfactants, growing use in green cleaning products, expansion of agricultural applications, increasing demand for biodegradable surfactants, focus on microbial fermentation scaling.
Increasing demand for personal care products is expected to drive the growth of the rhamnolipids market in the coming years. Personal care products include items such as skincare, haircare, oral care, and hygiene products used for grooming and maintaining cleanliness and appearance. The use of personal care products is rising due to higher disposable incomes, growing awareness of health and hygiene, evolving demographics, social media influence, and the expanding self-care trend. Rhamnolipids enhance personal care products by offering effective cleansing, moisturizing, and mild performance while providing eco-friendly and efficiency-improving advantages. For instance, in September 2024, according to the Bureau of Labor Statistics (BLS), a U.S.-based federal agency, U.S. household spending on personal care products and services increased by 9.7% in 2023 compared to 2022. Therefore, the rising demand for personal care products is fueling the growth of the rhamnolipids market.
Major companies in the rhamnolipids market are prioritizing advanced innovations, such as large-scale fermentation production capacity, to strengthen their competitive position. Industrial-scale rhamnolipid production involves manufacturing biosurfactants in high volumes through fermentation processes using renewable feedstocks, enabling broader use in cleaning, personal care, agriculture, and industrial sectors. For instance, in March 2025, AGAE Technologies, a US-based biosurfactant manufacturer, established a large-scale production plant in Asia capable of generating more than 1,000 metric tons of rhamnolipids annually. The facility incorporates upgraded fermentation and foam-control systems, offers both granular and liquid rhamnolipid forms, and supports further capacity expansion as demand increases. These advancements reduce unit costs and enhance supply stability, promoting wider adoption of rhamnolipids as sustainable alternatives. The increased production capability improves global supply chain strength, though companies must maintain consistent product quality and meet regulatory standards for large-scale distribution.
In January 2023, Sasol Limited, a South Africa-based supplier of chemicals, surfactants, and specialty solutions, broadened its strategic partnership with Holiferm Limited to develop and commercialize rhamnolipid-based sustainable surfactants. Through this extended collaboration, Sasol aimed to expand its portfolio of environmentally friendly surfactants, accelerate the market uptake of biodegradable biosurfactants, and integrate Holiferm’s rhamnolipid fermentation technology into its global product lines. Holiferm Limited is a US-based producer of microbial rhamnolipids and other biosurfactants for personal care, home care, and industrial cleaning applications.
Major companies operating in the rhamnolipids market are Jeneil Biotech Inc, AGAE Technologies LLC, Evonik Industries AG, Biotensidon GmbH, Shaanxi Deguan Biotechnology Co. Ltd, Zhejiang Silver‑Elephant Bio‑engineering Co. Ltd, Zhejiang Shengda Zijin Biotech Co. Ltd, TeeGene Biotech, Rhamnolipid Companies, Inc, Paradigm Biomedical Inc, Locus Bio‑Energy Solutions, Teego Technologies, Altinbio Scientific Private Limited, NatSurFact Laboratories, Aumgene Biosciences Pvt. Ltd, Jiangsu WanQi Biotechnology Co. Ltd, Rhamnolipid, Inc, Shandong Aikang Biotechnology, Xi’an Rege Biotechnology, Zilorium Biologics, Locus Performance Ingredients.
Asia-Pacific was the largest region in the rhamnolipids market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the rhamnolipids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the rhamnolipids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The rhamnolipids market consists of sales of complex rhamnolipids, uncommon rhamnolipids, household cleaners, and personal care products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Rhamnolipids Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses rhamnolipids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase::
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for rhamnolipids? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rhamnolipids market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Mono-Rhamnolipids; Di-Rhamnolipids2) By Form: Liquid; Powder
3) By Application: Surfactants; Cosmetics; Agriculture; Other Applications
Subsegments:
1) By Mono-Rhamnolipids: Rhamnolipid C10 (Mono-Rhamnolipid With 10-Carbon Chain); Rhamnolipid C12 (Mono-Rhamnolipid With 12-Carbon Chain); Rhamnolipid C14 (Mono-Rhamnolipid With 14-Carbon Chain); Other Mono-Rhamnolipids (Based on Different Fatty Acid Chains)2) By Di-Rhamnolipids: Di-Rhamnolipid C10 (Di-Rhamnolipid With 10-Carbon Chain); Di-Rhamnolipid C12 (Di-Rhamnolipid With 12-Carbon Chain); Di-Rhamnolipid C14 (Di-Rhamnolipid With 14-Carbon Chain); Other Di-Rhamnolipids (Based on Different Fatty Acid Chains)
Companies Mentioned: Jeneil Biotech Inc; AGAE Technologies LLC; Evonik Industries AG; Biotensidon GmbH; Shaanxi Deguan Biotechnology Co. Ltd; Zhejiang Silver‑Elephant Bio‑engineering Co. Ltd; Zhejiang Shengda Zijin Biotech Co. Ltd; TeeGene Biotech; Rhamnolipid Companies, Inc; Paradigm Biomedical Inc; Locus Bio‑Energy Solutions; Teego Technologies; Altinbio Scientific Private Limited; NatSurFact Laboratories; Aumgene Biosciences Pvt. Ltd; Jiangsu WanQi Biotechnology Co. Ltd; Rhamnolipid, Inc; Shandong Aikang Biotechnology; Xi’an Rege Biotechnology; Zilorium Biologics; Locus Performance Ingredients
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Rhamnolipids market report include:- Jeneil Biotech Inc
- AGAE Technologies LLC
- Evonik Industries AG
- Biotensidon GmbH
- Shaanxi Deguan Biotechnology Co. Ltd
- Zhejiang Silver‑Elephant Bio‑engineering Co. Ltd
- Zhejiang Shengda Zijin Biotech Co. Ltd
- TeeGene Biotech
- Rhamnolipid Companies, Inc
- Paradigm Biomedical Inc
- Locus Bio‑Energy Solutions
- Teego Technologies
- Altinbio Scientific Private Limited
- NatSurFact Laboratories
- Aumgene Biosciences Pvt. Ltd
- Jiangsu WanQi Biotechnology Co. Ltd
- Rhamnolipid, Inc
- Shandong Aikang Biotechnology
- Xi’an Rege Biotechnology
- Zilorium Biologics
- Locus Performance Ingredients
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | January 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.14 Billion |
| Forecasted Market Value ( USD | $ 4.37 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |


